Novartis AG's Fiscal Year is From January To December - All Figures are in Percent.
The item "Gross-Profit-Margin" stands at 76.21 percent as of 09/30/2025.
As of the end of Novartis AG's third quarter, the item "Gross Profit Margin" stands at 76.21 Percent. This represents a decrease of -0.04 percentage points compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 1.29 percentage points compared to the value the year prior.
The 1 year change in percentage points is 1.29.
The 3 year change in percentage points is 5.00.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Gross Profit Margin | 905,699,262,464.00 |
![]() | Johnson & Johnson - Gross Profit Margin | 486,508,953,600.00 |
![]() | AbbVie Inc - Gross Profit Margin | 399,570,305,024.00 |
![]() | Roche Holding AG - Gross Profit Margin | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Gross Profit Margin | 280,205,508,085.11 |